Independent Test Assessment Program (ITAP)

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) program has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable diagnostic tests.

Current Funding Opportunities

Please sign up for our newsletter to be notified when new opportunities are launched.

RADx® Tech Independent Test Assessment Program (ITAP) for Hepatitis B Virus Surface Antigen (HBsAg) Point-of-Care (POC)* Diagnostics

In collaboration with the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program is soliciting proposals to accelerate the validation, regulatory authorization, and commercialization of innovative point-of-care (POC) tests for hepatitis B virus surface antigen (HBsAg) detection.

Learn more and apply >

Past Funding Opportunities

ITAP for Diagnostic Mpox Lesion Panel

ITAP is not presently accepting new applications for Mpox Lesion Panel. Applications that were submitted by the deadline that meet all the previous eligibility criteria will be reviewed.

COVID-19 Tests

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative has established the Independent Test Assessment Program (ITAP) in order to accelerate regulatory review and availability of high-quality, accurate, and reliable over-the-counter COVID-19 tests to the public. ITAP is not presently accepting new applications for COVID-19 tests.

Multiplex Point-of-Care (POC) Diagnostic Tests

ITAP is not presently accepting new applications for multiplex point-of-care diagnostics tests. Applications that were submitted by December 16, 2022 that meet all the previous eligibility criteria will be reviewed.

MPox Virus Tests

ITAP is not presently accepting new applications for monkeypox virus tests. Applications that were submitted prior to October 17, 2022 that meet all the previous eligibility criteria will be reviewed.

Hepatitis C Virus Point-Of-Care Diagnostics

ITAP is not presently accepting new applications for Hepatitis C diagnostics. Applications that were submitted prior to March 12, 2023 that meet all the previous eligibility criteria will be reviewed.

Multiplex Over-the-Counter (OTC) Diagnostic Tests for COVID-19 and Flu

ITAP is not presently accepting new applications for monkeypox virus tests. Applications that were submitted prior to May 3, 2023 that meet all the previous eligibility criteria will be reviewed.